Asia Pacific Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valv

Asia Pacific Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

The Asia Pacific hydrocephalus shunts market is expected to grow from US$ 66.26 million in 2022 to US$ 82.49 million by 2028. It is estimated to grow at a CAGR of 3.7% from 2022 to 2028.

Business Synergy Through Strategic Alliances to Bring New Trends to the Asia Pacific Hydrocephalus Shunts Market

Companies in the hydrocephalus shunts market are implementing strategies such as joint ventures to enlarge their market shares. Investments in R&D allow them to develop advanced technologies and gain more revenues. For example, the Institute for Dynamic Systems and Control, and the Interface Group of the Institute of Physiology at the University of Zurich are jointly working on SmartShunt - The Hydrocephalus Project for the development of a smart CSF shunt for normal pressure hydrocephalus. Moreover, in 2020, Aesculap, Inc., in partnership with Christoph Miethke GmbH & Co. KG, announced the launch of the M.blue valve, the latest generation of their hydrocephalus valve technology. Many organizations are focused on developing smart shunts to provide advanced control, diagnosis, and communications with the use of implanted sensors, telemetry components, and feedback control systems. Thus, strategies such as collaborations and research alliances among key players are expected to contribute to the Asia Pacific hydrocephalus shunt market growth during the forecast period.

Asia Pacific Hydrocephalus Shunts Market Overview

The Asia Pacific hydrocephalus shunts market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The increasing prevalence of hydrocephalus in the region is a major factor contributing to the growth of the Asia Pacific hydrocephalus shunt market .

Asia Pacific Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Hydrocephalus Shunts Market Segmentation

The Asia Pacific hydrocephalus shunts market is segmented into age group, type, product, end user and country.

Based on age group, the Asia Pacific hydrocephalus shunts market is segmented into pediatric, and adults. The pediatric segment held the larger market share in 2022.

Based on type, the Asia Pacific hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held the largest market share in 2022.

Based on product, the Asia Pacific hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment dominated the market share in 2022.

Based on end user, the Asia Pacific hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, others. The hospital segment dominated the market share in 2022.

Based on country, the Asia Pacific hydrocephalus shunts market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia-Pacific. The China dominated the market share in 2022.

B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); HpBio Próteses, inc.; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the Asia Pacific hydrocephalus shunts market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific hydrocephalus shunts market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific hydrocephalus shunts market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution